Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - DEFERRED INCOME TAX
Deferred Income Tax OCX - OncoCyte Corporation
0
LAST VALUE
41.42%
2 YEAR CAGR
0.00%
5 YEAR CAGR
7.18%
10 YEAR CAGR